BLAINTRAMUSCULARINJECTION, SUSPENSION
Approved
Aug 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
3
Clinical Trials (3)
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.
Started Mar 2023
4,206 enrolled
SARS-CoV-2
Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy
Started Mar 2023
1,192 enrolled
Maternal OutcomesInfant OutcomesPregnancy
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
Started Apr 2022
1,500 enrolled
Myocarditis